Chinese Journal of Pharmaceuticals
|
2025, 56(3): 414-419
• Pharmaceutical Management & Information •
Application and Improvement of the BOLAR Exception Rule in China from the“Rivaroxaban” Case
Full
Jiayao HE
1, 2, Xuefang YAO
1, *
Affiliations
- 1.School of Health Economics and Management, Nanjing University of Chinese Medicine, Nanjing 210023
- 2.China Pharmaceutical University, Nanjing 211198
Published: 2025-03-10
doi: 10.16522/j.cnki.cjph.2025.03.017
Outline
何嘉瑶, 姚雪芳.
从“利伐沙班”案谈我国BOLAR例外规则的适用与完善.
中国医药工业杂志,
2025
, 56
(3)
: 414
-419
.
DOI: 10.16522/j.cnki.cjph.2025.03.017
Jiayao HE, Xuefang YAO.
Application and Improvement of the BOLAR Exception Rule in China from the“Rivaroxaban” Case[J].
Chinese Journal of Pharmaceuticals,
2025
, 56
(3)
: 414
-419
.
DOI: 10.16522/j.cnki.cjph.2025.03.017
Year 2025 volume 56 Issue 3
55
20
Cite this Article
BibTeX
Article Info
doi: 10.16522/j.cnki.cjph.2025.03.017
- Receive Date:2024-08-14
- Online Date:2026-11-17
- Published:2025-03-10